MedPath

SEGURIDAD MEDICA SEGANEST S A S

🇨🇴Colombia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Concentrations of Remifentanil for Extubation

Phase 4
Completed
Conditions
Cough
Interventions
Drug: Extubation T
Drug: Extubation U
First Posted Date
2016-03-17
Last Posted Date
2016-03-17
Lead Sponsor
Seganest
Target Recruit Count
110
Registration Number
NCT02711904
Locations
🇨🇴

Instituto Para Niños Ciegos y Sordos del Valle del Cauca, Santiago de Cali, Valle del Cauca, Colombia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.